In a landmark decision with wide-ranging implications for drugmakers around the globe, the European Medicines Agency (EMA) has announced it will soon require pharmaceutical companies whose products ...
The European Medicines Agency (EMA) has opened a new consultation on a draft guideline that would revise a set of biosimilar guidelines first put in place six years ago. The guideline, On non-clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results